Brian G. Weinshenker

Also affiliated with Mayo Clinic in Florida, University of Virginia

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 16 papers. Top paper: “Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial”.

Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial

The Lancet Neurology(2020)10.1016/s1474-4422(20)30078-8

N/A

6.8DataRank · unranked

499 citations

Benjamin Greenberg, Jeffrey L. Bennett, L Szczechowski, Edward Fox, Svitlana Shkrobot +8 more

Long-term safety of satralizumab in neuromyelitis optica spectrum disorder (NMOSD) from SAkuraSky and SAkuraStar

Multiple Sclerosis and Related Disorders(2022)10.1016/j.msard.2022.104025

N/A

2.9DataRank · unranked

62 citations

Brian G. Weinshenker, Michael R. Yeaman, de Sèze, Francesco Patti, Patricia Lobo +5 more

HTLV-1 Associated Myelopathy in Canada

Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques(1989)10.1017/s0317167100029176

N/A

0.775DataRank · unranked

14 citations

Brian G. Weinshenker, Gregory A. Dekaban, G.C. Ebers, Gordon S. Francis, George P.A. Rice +1 more

Comparison of MRI Lesion Evolution in Different Central Nervous System Demyelinating Disorders

Neurology(2021)10.1212/wnl.0000000000012467

N/A

0.760DataRank · unranked

158 citations

Karl N. Krecke, Steven A. Messina, Marina Buciuc, Sean J. Pittock, John J. Chen +15 more

Diagnosis of Progressive Multiple Sclerosis From the Imaging Perspective

JAMA Neurology(2020)10.1001/jamaneurol.2020.4689

N/A

0.633DataRank · unranked

67 citations

Paolo Preziosa, Frederik Barkhof, Declan Chard, Nicola De Stefano, Robert J. Fox +13 more

Reproductive history and progressive multiple sclerosis risk in women

Brain Communications(2020)10.1093/braincomms/fcaa185

N/A

0.609DataRank · unranked

57 citations

Elizabeth J. Atkinson, Delana Weis, Carin Y. Smith, Liliana Gazzuola Rocca, Walter A. Rocca +5 more

Critical spinal cord lesions associate with secondary progressive motor impairment in long-standing MS: A population-based case-control study

Multiple Sclerosis Journal(2020)10.1177/1352458520929192

N/A

0.457DataRank · unranked

20 citations

Steven A. Messina, B. Mark Keegan, Marina Buciuc, Sean J. Pittock, Orhun H. Kantarci +3 more

Attack adjudication in neuromyelitis optica spectrum disorder: Substantiation of criteria by magnetic resonance imaging and biomarkers in N-MOmentum

Multiple Sclerosis Journal(2023)10.1177/13524585231172145

N/A

0.373DataRank · unranked

11 citations

Dean M. Wingerchuk, Ari Green, Jeffrey L. Bennett, Ho Jin Kim, Sean J Pittock +14 more

Microfibrillar-associated protein 4 as a potential marker of acute relapse in inflammatory demyelinating diseases of the central nervous system: Pathological and clinical aspects

Multiple Sclerosis Journal(2023)10.1177/13524585231200720

N/A

0.208DataRank · unranked

3 citations

Mads Nikolaj Olesen, Martin Wirenfeldt, Sören Möller, Tatsuro Misu, Kerstin Soelberg +18 more

Effects of androgen modifying therapies on disease activity in older men with multiple sclerosis

Journal of Neuroimmunology(2025)10.1016/j.jneuroim.2025.578589

N/A

0.165DataRank · unranked

2 citations

Nur Neyal, Nabeela Nathoo, Manu Rangachari, Elizabeth J. Atkinson, Jiye Son +8 more

Protocol of a prospective multicenter study on comorbidity impact on multiple sclerosis and antibody-mediated diseases of the central nervous system (COMMIT)

Frontiers in Immunology(2024)10.3389/fimmu.2024.1380025

N/A

0DataRank · unranked

2 citations

Rafl Adnan, Paulina Berglova, Mahdi Barzegar, Birgit Debrabant, Stine Gundtoft Roikjær +23 more

Cerebellar Involvement in Attacks of Aquaporin-4-IgG Positive Neuromyelitis Optica Spectrum Disorder

Neurology Neuroimmunology & Neuroinflammation(2024)10.1212/nxi.0000000000200344

N/A

0DataRank · unranked

2 citations

Laura Cacciaguerra, Karl N. Krecke, John J. Chen, Dean M. Wingerchuk, Brian G. Weinshenker +7 more

Multiple sclerosis in Somali Americans: Nature or nurture?

Multiple Sclerosis and Related Disorders(2024)10.1016/j.msard.2024.105842

N/A

0DataRank · unranked

2 citations

Nur Neyal, Elizabeth J. Atkinson, Brian G. Weinshenker, Jan-Mendelt Tillema, B. Mark Keegan +11 more

Myelin-oligodendrocyte glycoprotein antibody-associated disease

The Lancet Neurology(2021)10.1016/s1474-4422(21)00218-0

N/A

0DataRank · unranked

519 citations

Yael Hacohen, Álvaro Cobo‐Calvo, Anne‐Katrin Pröbstel, Orhan Aktaş, Harry Alexopoulos +36 more

Application of 2015 Seronegative Neuromyelitis Optica Spectrum Disorder Diagnostic Criteria for Patients With Myelin Oligodendrocyte Glycoprotein IgG–Associated Disorders

JAMA Neurology(2020)10.1001/jamaneurol.2020.2743

N/A

0DataRank · unranked

20 citations

John J. Chen, Ruba Saadeh, Dean M. Wingerchuk, Brian G. Weinshenker, Eoin P. Flanagan +2 more

Clinical utility of AQP4-IgG titers and measures of complement-mediated cell killing in NMOSD

Neurology Neuroimmunology & Neuroinflammation(2020)10.1212/nxi.0000000000000727

N/A

0DataRank · unranked

65 citations

James P. Fryer, Masoud Majed, Carin Y. Smith, Sarah M. Jenkins, Philippe Cabre +13 more